Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Survival impact of rituximab combined with ACVBP and upfront consolidation autotransplantation in high-risk diffuse large B-cell lymphoma for GELA.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ أكثر حفظ في قائمتي
  • معلومة اضافية
    • Contributors:
      UCL - (SLuc) Service d'hématologie
    • الموضوع:
      2011
    • Collection:
      DIAL@USL-B (Université Saint-Louis, Bruxelles)
    • نبذة مختصرة :
      In high-risk diffuse large B-cell lymphoma patients, treatment with R-ACVBP followed by auto-transplantation results in a 78% 4-year overall survival which should be compared to other approaches.
    • ISSN:
      0390-6078
      1592-8721
    • Relation:
      boreal:132477; http://hdl.handle.net/2078.1/132477; info:pmid/21546499; urn:ISSN:0390-6078; urn:EISSN:1592-8721
    • الرقم المعرف:
      10.3324/haematol.2010.038109
    • الرقم المعرف:
      edsbas.F22D0153